Works matching IS 20406207 AND DT 2020 AND VI 11
Results: 53
HLA-mismatched donor and high ferritin level showed poor clinical outcomes after allogeneic hematopoietic cell transplantation in patients with advancedyelofibrosis.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720936935
- By:
- Publication type:
- Article
Experiences of allogeneic hematopoietic cell transplantation following non-myeloablative conditioning regimen in severely comorbid patients with myelofibrosis: case series with a patient presenting with extensive extramedullary hematopoiesis.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720932038
- By:
- Publication type:
- Article
Low-intensity regimens versus standard-intensity induction strategies in acute myeloid leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720913010
- By:
- Publication type:
- Article
Adverse events in second- and third-line treatments for acute and chronic graftversus-host disease: systematic review.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720977039
- By:
- Publication type:
- Article
Insights into the role of intestinal microbiota in hematopoietic stem-cell transplantation.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620719896961
- By:
- Publication type:
- Article
Allogeneic hematopoietic stem-cell transplantation for myelofibrosis.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720906002
- By:
- Publication type:
- Article
Optimizing outcomes in relapsed/refractory Hodgkin lymphoma: a review of current and forthcoming therapeutic strategies.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720902911
- By:
- Publication type:
- Article
CMV retinitis in a stem cell transplant recipient treated with foscarnet intravitreal injection and CMV specific immunoglobulins.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720975651
- By:
- Publication type:
- Article
Movement behaviour patterns in adults with haemophilia.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620719896959
- By:
- Publication type:
- Article
High CXCR2 expression predicts poor prognosis in adult patients with acute myeloid leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720958586
- By:
- Publication type:
- Article
Letermovir and its role in the prevention of cytomegalovirus infection in seropositive patients receiving an allogeneic hematopoietic cell transplant.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720937150
- By:
- Publication type:
- Article
One-year efficacy and safety of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria naïve to complement inhibitor therapy: open-label extension of a randomized study.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720966137
- By:
- Publication type:
- Article
Overt and non-overt disseminated intravascular coagulation and the potential role of heparin in the COVID-19 pandemic outbreak.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720951655
- By:
- Publication type:
- Article
BTK inhibitors and anti-CD20 monoclonal antibodies for treatment-naïve elderly patients with CLL.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720912990
- By:
- Publication type:
- Article
Safety and efficacy of axicabtagene ciloleucel in refractory large B-cell lymphomas.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720902899
- By:
- Publication type:
- Article
Primary lymphoma of bone: a population-based study of 2558 patients.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720958538
- By:
- Publication type:
- Article
Management of Epstein-Barr virus-related post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720910964
- By:
- Publication type:
- Article
Co-transplantation of mesenchymal stem cells makes haploidentical HSCT a potential comparable therapy with matched sibling donor HSCT for patients with severe aplastic anemia.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720965411
- By:
- Publication type:
- Article
Selinexor in relapsed/refractory multiple myeloma.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720930629
- By:
- Publication type:
- Article
Bispecific T-cell engaging antibodies in B-cell precursor acute lymphoblastic leukemias: focus on blinatumomab.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720919632
- By:
- Publication type:
- Article
Low dose continuous lenalidomide in heavily pretreated patients with relapsed or refractory classical Hodgkin lymphoma: a retrospective case series.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720947340
- By:
- Publication type:
- Article
Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720966121
- By:
- Publication type:
- Article
Current and novel therapies for the prevention of vaso-occlusive crisis in sickle cell disease.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720955000
- By:
- Publication type:
- Article
The role of fedratinib for the treatment of patients with primary or secondary myelofibrosis.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720925201
- By:
- Publication type:
- Article
BRD4 inhibitor nitroxoline enhances the sensitivity of multiple myeloma cells to bortezomib in vitro and in vivo by promoting mitochondrial pathway-mediated cell apoptosis.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720932686
- By:
- Publication type:
- Article
PET-adapted approaches to primary therapy for advanced Hodgkin lymphoma.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720914490
- By:
- Publication type:
- Article
octanate®: over 20 years of clinical experience in overcoming challenges in haemophilia A treatment.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720914692
- By:
- Publication type:
- Article
Personalized therapy in pediatric high-risk B-cell acute lymphoblastic leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720927575
- By:
- Publication type:
- Article
Efficacy of posaconazole prophylaxis in acute myeloid leukemia and myelodysplastic syndrome patients treated with hypomethylating agents.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720966882
- By:
- Publication type:
- Article
Older-age onset of Kimura's disease.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720962596
- By:
- Publication type:
- Article
Anti-leukemic effect of CDK9 inhibition in T-cell prolymphocytic leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720933761
- By:
- Publication type:
- Article
Management of toxicities associated with novel immunotherapy agents in acute lymphoblastic leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620719899897
- By:
- Publication type:
- Article
Effective treatment of refractory acquired pure red blood cell aplasia with eltrombopag and sirolimus: a case report.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720940144
- By:
- Publication type:
- Article
Posaconazole for the prophylaxis of invasive aspergillosis in acute myeloid leukemia: Is it still useful outside the clinical trial setting?
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720965846
- By:
- Publication type:
- Article
Advances in the understanding of poor graft function following allogeneic hematopoietic stem-cell transplantation.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720948743
- By:
- Publication type:
- Article
Early precursor T-cell acute lymphoblastic leukemia: current paradigms and evolving concepts.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720929475
- By:
- Publication type:
- Article
Disseminated focal <sup>18</sup>F-fluoro-deoxyglucose uptake upon granulocyte colony-stimulating factor therapy mimicking malignant bone infiltration: case report of a patient with very severe aplastic anemia.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720977613
- By:
- Publication type:
- Article
Pharmacokinetics in routine haemophilia clinical practice: rationale and modalities--a practical review.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720966888
- By:
- Publication type:
- Article
Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720955002
- By:
- Publication type:
- Article
Caplacizumab in adult patients with acquired thrombotic thrombocytopenic purpura.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720902904
- By:
- Publication type:
- Article
A rare atypical chronic myeloid leukemia BCR-ABL1 negative with concomitant JAK2 V617F and SETBP1 mutations: a case report and literature review.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720927105
- By:
- Publication type:
- Article
WEE1 inhibition synergizes with CHOP chemotherapy and radiation therapy through induction of premature mitotic entry and DNA damage in diffuse large B-cell lymphoma.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620719898373
- By:
- Publication type:
- Article
Gilteritinib in the treatment of relapsed and refractory acute myeloid leukemia with a FLT3 mutation.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720930614
- By:
- Publication type:
- Article
Nucleophosmin1 (NPM1) abnormality in hematologic malignancies, and therapeutic targeting of mutant NPM1 in acute myeloid leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620719899818
- By:
- Publication type:
- Article
Practical guidance for the management of acute lymphoblastic leukemia in the adolescent and young adult population.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720903531
- By:
- Publication type:
- Article
Incorporating hematopoietic stem-cell transplantation after second-line carfilzomiblenalidomide-dexamethasone (KRd).
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720921046
- By:
- Publication type:
- Article
Emerging treatment options for patients with high-risk myelodysplastic syndrome.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720955006
- By:
- Publication type:
- Article
The role of belantamab mafodotin for patients with relapsed and/or refractory multiple myeloma.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720979813
- By:
- Publication type:
- Article
Rescue treatment with eltrombopag in refractory cytopenias after allogeneic stem cell transplantation.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720961910
- By:
- Publication type:
- Article
The role of romiplostim for pediatric patients with immune thrombocytopenia.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720912992
- By:
- Publication type:
- Article